Bipolar II
Articles in this topic explain how Bipolar II can affect mood, focus, sleep, relationships, medication decisions, and day-to-day care conversations.
Caplyta off-label use
Caplyta (lumateperone) is one of the newer atypical antipsychotics, FDA-approved for schizophrenia and bipolar depression, and what's more interesting…
Apr 10, 2026
Lamictal (lamotrigine)
Lamictal is one of those medications I actually like prescribing, which is not a sentence I get to write very often in psychiatry.
Mar 8, 2026
Bipolar Disorder, Explained
Bipolar treatment goes wrong in the first appointment more often than in any later one. Get the diagnosis wrong and every prescription after it is wrong.
Aug 27, 2025
Mood Disorders Treatment
"Mood disorder" is a category, not a diagnosis.
May 7, 2025
Bipolar I vs Bipolar II vs Cyclothymia
These three diagnoses get confused constantly, including by clinicians, and the difference matters because the treatments diverge in important ways.
May 6, 2025
Caplyta (Lumateperone)
Caplyta is the antipsychotic that came out in 2019 and made a bunch of psychiatrists do a double-take at the receptor pharmacology, then another…
Apr 23, 2025